During treatment with LUMIGAN® 0.01% you may experience:

Increased eye redness (hyperemia)
Increased eyelash growth
Itchy eyes

In a 12-month clinical study with LUMIGAN® 0.01%, the most common adverse reaction was eye redness (31%). Approximately 1.6% of patients stopped therapy due to eye redness with LUMIGAN® 0.01%.

Talk to your doctor if you experience any side effects.